Comparison of nivolumab plus ipilimumab with tyrosine kinase inhibitors as first-line therapies for metastatic renal-cell carcinoma: a multicenter retrospective study
Year: 2020
Type: article
Study design: Observational Study
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: metastatic renal cell carcinoma, nivolumab plus ipilimumab, tyrosine kinase inhibitors, first-line therapy, immune checkpoint inhibitors, sunitinib, axitinib, sorafenib, pazopanib, objective response rate, progression-free survival, overall survival, real-world outcomes, IMDC risk stratification
Open Access status: closed
OpenAlex ID: W3092897271
